We did not observe a perturbation in the percentage of different immune cell subsets in mouse tumors comparing OTX015- to vehicle-treated mice, with only a trend of increase of tumor-infiltrated NKs that did not reach statistical significance (Fig. 7G, H ).
← all excerpts
BET inhibitors drive Natural Killer activation in non-small cell lung cancer via BRD4 and SMAD3.
1
—
—